| The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages L Schaefer, A Babelova, E Kiss, HJ Hausser, M Baliova, M Krzyzankova, ... The Journal of clinical investigation 115 (8), 2223-2233, 2005 | 987 | 2005 |
| Role of serum amyloid A during metabolism of acute-phase HDL by macrophages A Artl, G Marsche, S Lestavel, W Sattler, E Malle Arteriosclerosis, thrombosis, and vascular biology 20 (3), 763-772, 2000 | 315 | 2000 |
| Uremia alters HDL composition and function M Holzer, R Birner-Gruenberger, T Stojakovic, D El-Gamal, V Binder, ... Journal of the American Society of Nephrology 22 (9), 1631-1641, 2011 | 300 | 2011 |
| Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid E Malle, G Marsche, J Arnhold, MJ Davies Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2006 | 235 | 2006 |
| Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1 J Stefulj, U Panzenboeck, T Becker, B Hirschmugl, C Schweinzer, I Lang, ... Circulation research 104 (5), 600-608, 2009 | 194 | 2009 |
| Psoriasis alters HDL composition and cholesterol efflux capacity [S] M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, ... Journal of lipid research 53 (8), 1618-1624, 2012 | 178 | 2012 |
| Protein carbamylation renders high-density lipoprotein dysfunctional M Holzer, M Gauster, T Pfeifer, C Wadsack, G Fauler, P Stiegler, ... Antioxidants & redox signaling 14 (12), 2337-2346, 2011 | 165 | 2011 |
| E-type prostanoid receptor 4 (EP4) in disease and therapy V Konya, G Marsche, R Schuligoi, A Heinemann Pharmacology & therapeutics 138 (3), 485-502, 2013 | 162 | 2013 |
| Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival A Theiler, T Bärnthaler, W Platzer, G Richtig, M Peinhaupt, S Rittchen, ... Journal of Allergy and Clinical Immunology 144 (3), 764-776, 2019 | 153 | 2019 |
| Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake … G Marsche, A Hammer, O Oskolkova, KF Kozarsky, W Sattler, E Malle Journal of Biological Chemistry 277 (35), 32172-32179, 2002 | 149 | 2002 |
| 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein–associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis G Marsche, R Heller, G Fauler, A Kovacevic, A Nuszkowski, W Graier, ... Arteriosclerosis, thrombosis, and vascular biology 24 (12), 2302-2306, 2004 | 138 | 2004 |
| Inflammation alters HDL composition and function: implications for HDL-raising therapies G Marsche, MD Saemann, A Heinemann, M Holzer Pharmacology & therapeutics 137 (3), 341-351, 2013 | 136 | 2013 |
| Hypochlorite-modified low density lipoprotein inhibits nitric oxide synthesis in endothelial cells via an intracellular dislocalization of endothelial nitric-oxide synthase A Nuszkowski, R Gräbner, G Marsche, A Unbehaun, E Malle, R Heller Journal of Biological Chemistry 276 (17), 14212-14221, 2001 | 136 | 2001 |
| Redox state of human serum albumin in terms of cysteine-34 in health and disease K Oettl, G Marsche Methods in enzymology 474, 181-195, 2010 | 133 | 2010 |
| Aging affects high-density lipoprotein composition and function M Holzer, M Trieb, V Konya, C Wadsack, A Heinemann, G Marsche Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2013 | 130 | 2013 |
| Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins E Malle, G Marsche, U Panzenboeck, W Sattler Archives of biochemistry and biophysics 445 (2), 245-255, 2006 | 121 | 2006 |
| Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology R Birner-Gruenberger, M Schittmayer, M Holzer, G Marsche Progress in lipid research 56, 36-46, 2014 | 116 | 2014 |
| Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo G Marsche, S Frank, A Hrzenjak, M Holzer, S Dirnberger, C Wadsack, ... Circulation research 104 (6), 750-757, 2009 | 116 | 2009 |
| Obesity-related changes in high-density lipoprotein metabolism and function JT Stadler, G Marsche International journal of molecular sciences 21 (23), 8985, 2020 | 109 | 2020 |
| Anti-psoriatic therapy recovers high-density lipoprotein composition and function M Holzer, P Wolf, M Inzinger, M Trieb, S Curcic, L Pasterk, W Weger, ... Journal of Investigative Dermatology 134 (3), 635-642, 2014 | 109 | 2014 |
Akos HeinemannMedical University of GrazBestätigte E-Mail-Adresse bei medunigraz.at
